HTL Biotechnology
Accelerator•Series A/B • France
HTL Innovations provides a seed funding support and a minority financial support. HTL Biotechnology is a French biotech and a world leader in the development and responsible bioproduction of pharmaceutical-grade biopolymers (Hyaluronic acid, polynucleotides). These biopolymers are used by healthcare companies for the development of treatments in various cutting-edge therapeutic areas such as ophthalmology, dermatology, medical aesthetics and rheumatology.HTL Innovations
Investment Areas
Typical Investment
0-€100k
Funding Stage
Series A/B
Headquarters
France